Cryo-Cell International(CCEL)
$5.14+0.27 (+5.54%)
CCEL
Cryo-Cell International financials statements
$5.14
At close:+0.27 (+5.54%)
Want to see CCEL full AI Analyst Report?
Cryo-Cell International (CCEL) Ratios
57 Followers
Cryo-Cell International Ratios
CCEL's free cash flow for Q3 2026 was $1.04M. For the 2026 fiscal year, CCEL's free cash flow was decreased by $-101.88K and operating cash flow was $1.14M. See a summary of the company’s cash flow.
| Ratios | Nov 25 | Feb 25 | Nov 23 | Feb 23 | Nov 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.59 | 0.58 | 0.45 | 0.49 | 0.75 |
| Quick Ratio | 0.57 | 0.55 | 0.42 | 0.45 | 0.71 |
| Cash Ratio | 0.02 | 0.03 | 0.02 | 0.09 | 0.39 |
| Solvency Ratio | -0.01 | 0.01 | -0.11 | 0.07 | 0.06 |
| Operating Cash Flow Ratio | 0.28 | 0.28 | 0.43 | 0.44 | 0.38 |
| Short-Term Operating Cash Flow Coverage | 2.21 | 1.63 | 6.42 | 3.54 | 4.18 |
| Net Current Asset Value | $ -68.58M | $ -65.34M | $ -62.80M | $ -56.80M | $ -40.70M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.20 | 0.18 | 0.18 | 0.05 |
| Debt-to-Equity Ratio | -0.62 | -0.98 | -0.99 | -7.62 | 0.67 |
| Debt-to-Capital Ratio | -1.64 | -45.85 | -80.59 | 1.15 | 0.40 |
| Long-Term Debt-to-Capital Ratio | -0.78 | -1.69 | -3.24 | 1.22 | 0.00 |
| Financial Leverage Ratio | -3.32 | -4.89 | -5.55 | -42.57 | 14.50 |
| Debt Service Coverage Ratio | 0.22 | -0.18 | -2.50 | 1.55 | 1.46 |
| Interest Coverage Ratio | 2.34 | 1.87 | -9.95 | 2.64 | 2.91 |
| Debt to Market Cap | 0.33 | 0.17 | 0.22 | 0.30 | 0.02 |
| Interest Debt Per Share | 1.69 | 1.82 | 1.45 | 1.55 | 0.52 |
| Net Debt to EBITDA | 10.24 | 8.70 | -1.01 | 1.49 | -1.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 76.63% | 75.15% | 73.07% | 71.02% | 68.88% |
| EBIT Margin | -0.86% | 2.94% | -38.69% | 15.96% | 13.81% |
| EBITDA Margin | 3.48% | 4.45% | -33.24% | 21.92% | 18.41% |
| Operating Profit Margin | 15.34% | 10.88% | -39.26% | 13.27% | 13.91% |
| Pretax Profit Margin | -7.40% | 8.77% | -42.64% | 10.94% | 9.04% |
| Net Profit Margin | -7.70% | 1.26% | -30.38% | 9.14% | 7.21% |
| Continuous Operations Profit Margin | -7.70% | 1.26% | -30.38% | 9.14% | 7.21% |
| Net Income Per EBT | 103.95% | 14.34% | 71.25% | 83.50% | 79.79% |
| EBT Per EBIT | -48.28% | 80.57% | 108.62% | 82.47% | 64.98% |
| Return on Assets (ROA) | -3.94% | 0.62% | -15.55% | 4.27% | 3.43% |
| Return on Equity (ROE) | 13.06% | -3.04% | 86.32% | -181.81% | 49.79% |
| Return on Capital Employed (ROCE) | 11.54% | 8.08% | -30.49% | 8.86% | 10.15% |
| Return on Invested Capital (ROIC) | 10.79% | 1.06% | -20.89% | 6.98% | 7.67% |
| Return on Tangible Assets | -4.12% | 0.65% | -16.33% | 5.80% | 4.90% |
| Earnings Yield | -7.56% | 0.57% | -21.34% | 7.49% | 2.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.61 | 4.38 | 4.77 | 5.02 | 5.50 |
| Payables Turnover | 2.57 | 4.22 | 2.66 | 5.48 | 6.03 |
| Inventory Turnover | 18.04 | 12.08 | 10.98 | 10.33 | 9.76 |
| Fixed Asset Turnover | 1.44 | 1.41 | 1.42 | 2.14 | 6.97 |
| Asset Turnover | 0.51 | 0.49 | 0.51 | 0.47 | 0.48 |
| Working Capital Turnover Ratio | -3.70 | -3.13 | -2.95 | -4.00 | -18.34 |
| Cash Conversion Cycle | -42.66 | 27.17 | -27.43 | 41.41 | 43.30 |
| Days of Sales Outstanding | 79.16 | 83.41 | 76.58 | 72.72 | 66.38 |
| Days of Inventory Outstanding | 20.23 | 30.20 | 33.24 | 35.34 | 37.40 |
| Days of Payables Outstanding | 142.05 | 86.44 | 137.25 | 66.64 | 60.49 |
| Operating Cycle | 99.39 | 113.61 | 109.82 | 108.06 | 103.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.68 | 0.74 | 1.07 | 1.01 | 0.97 |
| Free Cash Flow Per Share | 0.65 | 0.30 | 0.15 | -1.02 | 0.12 |
| Dividend Paid and CapEx Coverage Ratio | 1.58 | 1.07 | 1.17 | 0.35 | 1.14 |
| Capital Expenditure Coverage Ratio | 23.77 | 1.67 | 1.17 | 0.50 | 1.14 |
| Operating Cash Flow Coverage Ratio | 0.47 | 0.46 | 0.82 | 0.74 | 2.81 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.19 | 0.28 | 0.28 | 0.27 |
| Free Cash Flow Yield | 16.34% | 3.41% | 2.87% | -23.24% | 0.97% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -13.27 | 175.31 | -4.69 | 13.35 | 48.35 |
| Price-to-Sales (P/S) Ratio | 1.02 | 2.20 | 1.42 | 1.22 | 3.49 |
| Price-to-Book (P/B) Ratio | -1.73 | -5.33 | -4.05 | -24.27 | 24.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.12 | 29.28 | 34.84 | -4.30 | 103.33 |
| Price-to-Operating Cash Flow Ratio | 5.86 | 11.73 | 5.00 | 4.32 | 12.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -1.68 | 0.01 | 0.50 | -1.05 |
| Enterprise Value Multiple | 39.51 | 58.23 | -5.29 | 7.05 | 17.92 |
| Enterprise Value | 43.35M | 82.87M | 55.11M | 46.90M | 95.30M |
| EV to EBITDA | 39.51 | 58.23 | -5.29 | 7.05 | 17.92 |
| EV to Sales | 1.37 | 2.59 | 1.76 | 1.55 | 3.30 |
| EV to Free Cash Flow | 8.26 | 34.42 | 43.03 | -5.46 | 97.75 |
| EV to Operating Cash Flow | 7.91 | 13.79 | 6.18 | 5.47 | 12.02 |
| Tangible Book Value Per Share | -2.65 | -1.98 | -1.67 | -2.20 | -1.72 |
| Shareholders’ Equity Per Share | -2.31 | -1.63 | -1.32 | -0.18 | 0.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.04 | 0.86 | 0.29 | 0.16 | 0.20 |
| Revenue Per Share | 3.91 | 3.93 | 3.76 | 3.58 | 3.55 |
| Net Income Per Share | -0.30 | 0.05 | -1.14 | 0.33 | 0.26 |
| Tax Burden | 1.04 | 0.14 | 0.71 | 0.84 | 0.80 |
| Interest Burden | 8.63 | 2.98 | 1.10 | 0.69 | 0.65 |
| Research & Development to Revenue | 0.01 | 0.04 | 0.04 | 0.01 | 0.00 |
| SG&A to Revenue | 0.58 | 0.58 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.03 | 0.02 | 0.01 |
| Income Quality | -2.26 | 14.95 | -0.94 | 3.09 | 3.80 |
Currency in USD
